Create Alert
Watchlist

Bharat Immunological

₹20.22
+1.88 (10.25%) 1D
BSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
18.50
Prev. Close
18.34
Volume
27,411
Total traded value
0.06 Cr
Upper Circuit
22.00
Lower Circuit
14.68

Fundamentals

Market Cap₹79Cr
ROE-22.95%
P/E Ratio(TTM)-4.39
EPS(TTM)-4.18
P/B Ratio0.00
Dividend Yield0.00%
Industry P/E39.79
Book Value-7.54
Debt to Equity0.94
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About BIBCOL

Bharat Immunologicals & Biologicals Corporation Limited is a Government of India company established to produce and supply Oral Polio Vaccine for national immunization efforts. From its very beginning, the company has played a major role in the National Immunizations Programme by providing billions of doses of its primary vaccine. To expand its offerings, the company is diversifying into making an Oral Cholera Vaccine, with a new manufacturing facility under construction. Furthermore, the company is seeking approval for its Covaxin Project, which aims to increase the overall production of Covaxin within the country. The company's main source of revenue comes from its vaccine segment, primarily through supply orders from the Ministry of Health and Family Welfare. During the year, its vaccine supply orders generated net sales of ₹7838.80 lakhs, showcasing its key role in public health.;
Parent OrganisationBharat Immunologicals & Biologicals Corporation Limited
Managing DirectorDr. Sanjay Mishra
Founded1989
BSE Symbol524663

Shareholding Pattern

Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Promoters
59.25%
Retail And Others
40.75%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
59.51
Ajanta Pharma
NA
(0.00%)
33.61
Gland Pharma
NA
(0.00%)
35.69
Eris Lifesciences
NA
(0.00%)
51.62
Recent news is not available for this stock
This stock has no events currently